受强制性开放获取政策约束的文章 - Paul Maciocia了解详情
无法在其他位置公开访问的文章：1 篇
Treatment of diffuse large B‐cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS‐penetrating R‐IDARAM chemotherapy
P Maciocia, M Badat, S Cheesman, S D'Sa, R Joshi, J Lambert, ...
British journal of haematology 172 (4), 545-553, 2016
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
可在其他位置公开访问的文章：7 篇
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies
PM Maciocia, PA Wawrzyniecka, B Philip, I Ricciardelli, AU Akarca, ...
Nature medicine 23 (12), 1416-1423, 2017
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
An APRIL-based chimeric antigen receptor for dual targeting of BCMA and TACI in multiple myeloma
L Lee, B Draper, N Chaplin, B Philip, M Chin, D Galas-Filipowicz, ...
Blood, The Journal of the American Society of Hematology 131 (7), 746-758, 2018
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, National Institute for Health Research, UK
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia
PM Maciocia, PA Wawrzyniecka, NC Maciocia, A Burley, T Karpanasamy, ...
Blood, The Journal of the American Society of Hematology 140 (1), 25-37, 2022
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council, National …
Chimeric antigen receptor T cells for gamma–delta T cell malignancies
PA Wawrzyniecka, L Ibrahim, G Gritti, MA Pule, PM Maciocia
Leukemia 36 (2), 577-579, 2022
强制性开放获取政策： Cancer Research UK
A new prognostic model for myeloma patients relapsing from upfront autologous transplantation based on ISS and PFS1
SJ Chavda, PM Maciocia, P Mesiri, N Counsell, J Kothari, A Bird, ...
British journal of haematology 185 (2), 350-353, 2019
强制性开放获取政策： National Institute for Health Research, UK
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: A phase 1/2 trial
K Cwynarski, G Iacoboni, E Tholouli, T Menne, DA Irvine, ...
Nature Medicine, 1-7, 2024
强制性开放获取政策： UK Research & Innovation
Anti-CD21 Chimeric Antigen Receptor T cells for the Treatment of T Cell Acute Lymphoblastic Leukemia
N Maciocia, A Burley, M Hoekx, F Nannini, P Wawrzyniecka, ...
强制性开放获取政策： Blood Cancer UK, Cancer Research UK, UK Medical Research Council
出版信息和资助信息由计算机程序自动确定